Canonical: https://ownershiptrace.com/13f/companies/3337

# Who owns Viridian Therapeutics, Inc.\\DE (MGEN)? Elite investor 13F holders

3 tracked elite investors reported holding Viridian Therapeutics, Inc.\\DE as of 2026-06-30, including Caligan Partners, D.E. Shaw, Renaissance Technologies LLC. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

3 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Viridian Therapeutics, Inc. engages in discovering, developing, and commercializing treatments for serious and rare diseases. It develops IGF-1R therapies to treat thyroid eye disease (TED), including Veligrotrug, a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered, and Elegrobart, a low-volume, infrequently dosed subcutaneous IGF-1R. The company also…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [Caligan Partners](https://ownershiptrace.com/13f/investors/125) | VIRIDIAN THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 40303431.00 USD | 2193981.000000 | Shares | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/1727492/0001420506-26-001809-index.html) |
| [D.E. Shaw](https://ownershiptrace.com/13f/investors/98) | VIRIDIAN THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 21717418.00 USD | 1182222.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1009207/0001104659-26-097217-index.html) |
| [Renaissance Technologies LLC](https://ownershiptrace.com/13f/investors/63) | VIRIDIAN THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 14119182.00 USD | 768600.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1037389/0001037389-26-000059-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)